Featured Content
Pfizer has made a $35 million investment — through its Pfizer "Breakthrough Growth Initiative" — in autoimmune disease treatment biotechnology…
Pfizer has made a $35 million investment — through its Pfizer "Breakthrough Growth Initiative" — in autoimmune disease treatment biotechnology…